Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by educational grants from Amgen, Inc. and Takeda Oncology.

Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Acute Lymphocytic Leukemia

Release Date: December 22, 2020
Expiration Date: December 22, 2021

Activity Overview

This online activity is designed to update clinicians on data presented at the American Society of Hematology Annual Meeting (ASH 2020), held as an all-virtual event December 5 to December 8, 2020, and will help facilitate critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 5 abstracts from ASH 2020 that are focused on acute lymphoblastic leukemia (ALL). For each abstract, a text summary of key clinical data is accompanied by perspectives from expert thought leaders who provide insights into how clinicians can apply these findings to their clinical practice to improve patient care.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Amgen, Inc. and Takeda Oncology.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward medical oncologists and hematologists who treat patients with ALL. Fellows, nurses, nurse practitioners, physician assistants, and other health care professionals (HCPs) involved in the management of patients with ALL will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Explain the rationale and study design for recently reported and ongoing clinical trials for ALL
  • Evaluate safety and efficacy data from recently reported clinical trials for patients with ALL
  • Place emerging data in the context of evolving treatment paradigms for patients with ALL

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Elias Jabbour, MD
Elias Jabbour, MD
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant/Research Support: Amgen, AbbVie, Spectrum, Bristol Myers Squibb, Takeda, Pfizer, Adaptive Biotechnologies, Genetech.

Hagop M. Kantarjian, MD
Hagop M. Kantarjian, MD
Professor of Clinical Dermatology
Samsung Distinguished University Chair in Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant/Research Support: AbbVie, Amgen, Ascentage, BMS, Daiichi Sankyo, Immunogen, Jazz, Pfizer, Sanofi; Other: (Honoraria) AbbVie, Actinium, Adaptive Biotechnologies, Amgen, Apptitude Health, BioAscend, Daiichi Sankyo, Delta Fly, Janssen Global, Novartis, Oxford Bio, Pfizer, Takeda.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By